Timo O Odinius

Years Active: 2019-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Veronika Dill, Celina Victoria Wagner, Eva C Keller, Francisco Jose Fernandez-Hernandez, Khalid Shoumariyeh, Timo O Odinius, Lars Buschhorn, Richard T Hauch, Christian Suren, Judith S Hecker, Peter Herhaus, Michael Sandherr, Burkhard Schmidt, Julia Slotta-Huspenina, Florian Bassermann, Ulrike Höckendorf, Stefanie Jilg, Caterina Branca, Sebastian Vosberg, Philipp J Jost
Elevated RIPK3 correlates with disease burden in myelofibrosis. Blood advances (2022)
Veronika Dill, Johanna Kauschinger, Richard T Hauch, Lars Buschhorn, Timo O Odinius, Catharina Müller-Thomas, Ritu Mishra, Michele C Kyncl, Burkhard Schmidt, Peter M Prodinger, Dirk Hempel, Frauke Bellos, Alexander Höllein, Wolfgang Kern, Torsten Haferlach, Julia Slotta-Huspenina, Florian Bassermann, Christian Peschel, Katharina S Götze, Irene C Waizenegger, Ulrike Höckendorf, Philipp J Jost, Stefanie Jilg
Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis. European journal of haematology 104 (2) (2019)

Timo O Odinius.css-eqlu8i{font-size:small;padding-left:4px;}